In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit
暂无分享,去创建一个
J. Trepel | P. Cabrales | T. Reid | Y. Tomita | Min-Jung Lee | B. Oronsky | Sunmin Lee | A. Yuno | Nacer D. Abrouk | Jonathan Baker